The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Firstly 30000 is the worst flu year ever (excluding Spanish flu).
Secondly flu doesn’t spread all year round, it’s a winter virus which on average kills 20000 a year.
We won’t know how they compare until you at least have a similar variable, such as winter!
David allmond won’t be CEO until October, therefore the H1 audited results will be released by GM pre September, that’s at least how I read the RNS. Feel free to correct me if I’m wrong.
I don’t understand not releasing a trading update, completely agree the one month is key, especially with the lack of comms at the moment.
This government is mad, tell you what, why don’t we make seatbelts advisory not law, drink driving, drugs, smoking indoors etc. I wonder how many people will do the right thing…?
They’re abdicating all responsibility, I can’t figure out why!
Johnpohn, the half year trading update was beginning of July last year. This will have been delayed with the issues surrounding the DHSC whilst trying to get the audited results out.
It’s not early, technically it’s late and most expect it to be out by the end of July.
I have to say the (UK) is becoming a laughing stock. Balearic Islands put on the amber list when their rate is 205 per 100,000, the (UK) rate is 330 per 100,000. I genuinely think we will soon be on every other countries red list. It’s the blind leading the blind.
The only thing that’s good to come out of this for the company is the shear amount of testing that will be required; I 100% believe that figures will come in above those forecast. When the company released the FY results I bet they didn’t expect what’s happening now, leading to the inevitable testing surge.
I’ll add the mrs and I went for a PCR test today, I do a LFT every day, she’s done 2 this week but has lost her taste and smell.
Cutting to the chase, it used to be medex solutions that did the drive through PCR testing, the packaging has changed and so has the swab. No idea who it is now though…
We all talk about the fact we don’t know how long COVID testing measures will stay. It’s been staring us in the face since day one. A lot of scientific papers and business magazines discuss COVID staying and the diagnostic market continuing to grow until 2030 (previously 2027). Last night sky news released that a Conservative party paper has been produced listing winter measures that will likely be required for the next 5 years to combat COVID. Seem like revenue will taper off to you?
No…. I agree they need an alternate revenue stream, which they are working on. Until then the cash pile will grow.
Covid opportunist, avata used 98 samples (less than a 1/3 of NCYT) which isn’t enough for validation according to the MHRA, at a terrible ct to get its sensitivity so wind your neck in. Hope you enjoy buying your short back.
Covidopportunist, those sensitivity levels are great. If you look at other companies that did clinical validations they used less than 100 samples. NCYT did over 300. Innova is 70 odd %.
AVCT also stipulated based on ct value skewing the results.
Upsidedo I do agree, during the vaccine trials (although included 10000) only about 100-160 people actually got COVID, skewing the stats to 95% efficacy. I’ve always called bullsh*t as there wasn’t enough data to justify it.
@upsidedownowl
If you look at the government data (not in the media) : https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/994839/Variants_of_Concern_VOC_Technical_Briefing_16.pdf
45% of COVID deaths in the last week we’re fully vaccinated + 14 days people. That doesn’t sound like a 99% effective vaccine against death.
https://twitter.com/drericding/status/1407033868914499585?s=21
Vaccine alone will not stop this, 45% of deaths double vaccinated + 14 days.
Morning sun, what I don’t understand is the reason for it to be played, normally it would be:
Enable funds to load up.
Someone loading for a hotile bid.
Cause weak holders to sell pre big rise.
No one is increasing a holding. There are no buys / sells big enough to warrant trading for a couple of percent each day. There is no huge rise for the MM to coerce people to buy into.
If baffles me.
71 mil shares in issue
£132,423mil profit after tax
EPS = £1.87
PE = 1.95
Net Assets £150,710mil
NAV = 2.12
Strongest fundamental ever on AIM when compared to MCAP. It will take a while for funds to digest, this will climb over the coming weeks, just need to sit back now.